Restored thyroid receptor makes aggressive tumors more vulnerable to CAR-T cell therapy
Mayo Clinic researchers have identified a strategy that could help chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, overcome a major barrier to treating solid tumors: Cancer cells can change in ways that allow ...
Sep 18, 2026
0
9









